Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage

• Daniel Carbajo,

  Current address: Singapore Immunology Network (SigN), Singapore, Singapore

  Affiliation Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY, United States of America

  ⨯
• Shigeyuki Magi,

  Affiliation Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Japan

  ⨯
• Masayoshi Itoh,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako-shi, Japan

  ⨯
• Hideya Kawaji,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako-shi, Japan

  ⨯
• Timo Lassmann,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, Telethon Kids Institute, The University of Western Australia, Subiaco, Western Australia, Australia

  ⨯
• Erik Arner,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, Department of Medicine, Karolinska Institutet and Center for Metabolism and Endocrinology, Karolinska University Hospital, Stockholm, Sweden

  ⨯
• Alistair R. R. Forrest,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, Western Australia, Australia

  ⨯
• Piero Carninci,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan

  ⨯
• Yoshihide Hayashizaki,

  Affiliations RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako-shi, Japan

  ⨯
• Carsten O. Daub,

  Affiliations RIKEN Center for Life Science Technologies (Division of Genomic Technologies), Tsurumi-ku, Yokohama, Japan, RIKEN Omics Science Center, Tsurumi-ku, Yokohama, Japan, Department of Biosciences and Nutrition and Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden

  ⨯
• FANTOM consortium ,

  ¶Membership of the FANTOM Consortium is provided in S1 Table.

  ⨯
• Mariko Okada-Hatakeyama ,

  * E-mail: marikoh@riken.jp (MO); jessica.mar@einstein.yu.edu (JCM)

  Affiliation Laboratory for Integrated Cellular Systems, RIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Japan

  ⨯
• Jessica C. Mar

  * E-mail: marikoh@riken.jp (MO); jessica.mar@einstein.yu.edu (JCM)

  Affiliations Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY, United States of America, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, United States of America

  ⨯